RC
IRMD icon

Roubaix Capital’s iRadimed IRMD Stock Holding History

Roubaix Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71,497
Closed -$4.27M – 59
2025
Q2 		$4.27M Buy
71,497
+23,371
+49% +$1.28M 2.05% 20
2025
Q1 		$2.53M Buy
+48,126
New +$2.7M 1.32% 42
2024
Q2 		– Sell
-50,307
Closed -$2.21M – 55
2024
Q1 		$2.21M Buy
+50,307
New +$2.22M 1.4% 33
2019
Q4 		– Sell
-65,781
Closed -$1.38M – 41
2019
Q3 		$1.38M Buy
+65,781
New +$1.34M 1.26% 30

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Roubaix Capital's IRMD Position: Q3 2025 in Review

Roubaix Capital sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 71,497 shares — an estimated $4.27M sold.

Roubaix Capital first reported a position in IRMD in Q3 2019 and held it in 4 quarters. The position peaked at $4.27M in Q2 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Roubaix Capital reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
  • Roubaix Capital sold 71,497 iRadimed shares in Q3 2025, an estimated $4.27M.
  • Roubaix Capital first reported a position in iRadimed in Q3 2019 and held it in 4 quarters.
  • Roubaix Capital's iRadimed position peaked at $4.27M in Q2 2025.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Roubaix Capital's 13F filing for Q3 2025, filed 12 Nov 2025.